Clinical Trials on Anti-cancer Cell Immunotherapy

Total 9377 results

Second Affiliated Hospital of Guangzhou Medical...
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.

Recruiting

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Anti-cancer Cell Immunotherapy | T Cell and NK Cell

China
Sun Yat-sen University

Recruiting

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

Immunotherapy | DMMR Colorectal Cancer | Anti PD-1

China
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Lei Li

Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical Cancer

China
Second Affiliated Hospital of Zunyi Medical University
Guizhou Provincial People's Hospital; The First People's Hospital of Zunyi; Guizhou... and other collaborators

Recruiting

Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Immunotherapy | Second-line Treatment

China
University Health Network, Toronto

Active, not recruiting

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Advanced Cancer | Immunotherapy | Radiation Therapy | Palliative

Canada
Ankara Medipol University

Recruiting

The Effect of Education and Telephone Follow-up Given to Cancer Patients Receiving Immunotherapy on Symptom Management and Self-care Power

Self Care | Immunotherapy | Symptom Management | Cancer Patient

Turkey
Centre Francois Baclesse

Completed

Study of the Cognition of Patients Treated With Immunotherapy (COG-IMMUNO)

Patients With Cancer Who Start Immunotherapy | All Neoplasms

France
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Extravasations of Anthracycline Anti-cancer Agents

Japan
Eskisehir Osmangazi University
TC Erciyes University

Completed

The Effects of Antibiotic Combinations on Stem Cells

Anti-Bacterial Agents | Stem Cells

Turkey
Ascendis Pharma Oncology Division A/S

Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or Chemotherapy or TransCon TLR7/8 Agonist in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (IL Believe)

Advanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...

United States, Australia, Korea, Republic of
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Advanced Liver Cancer | Precision Cell Immunotherapy | Transcatheter Arterial Chemoembolization

China
Michael Scharl

Recruiting

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Cancer | Immunotherapy | Immune Checkpoint Inhibitors | Fecal Microbiota Transplantation

Switzerland
Central Adelaide Local Health Network Incorporated
Vaxine Pty Ltd

Unknown

Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) (Jumpvax)

Immunotherapy | Ant Sting

Australia
Viome
AdventHealth

Recruiting

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Gynecologic Cancer | Immunotherapy | Gut Microbiome

United States
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Gastric Cancer | Precision Cell Immunotherapy

China
Shanghai International Medical Center

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Malignancies | Precision Cell Immunotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer (PICARES)

Extensive-stage Small Cell Lung Cancer | Radiotherapy | Immunotherapy

China
Guangdong Association of Clinical Trials

Recruiting

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Lung Cancer | Immunotherapy

China
Hubei Cancer Hospital

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Non Small Cell Lung Cancer | Radiotherapy | Immunotherapy | Locally Advanced

China
Northern Jiangsu Province People's Hospital
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Neoadjuvant Therapy | Radiotherapy | Immunotherapy

China
Guangzhou FineImmune Biotechnology Co., LTD.

Recruiting

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors (TAL-T)

Advanced Solid Tumor | Immunotherapy | Tumor Associated Lymph Node T Cell

China
Lei Li

Recruiting

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1

China
Second Affiliated Hospital of Guangzhou Medical...
Guangdong Zhaotai InVivo Biomedicine Co. Ltd.; Hunan Zhaotai Yongren Medical...

Recruiting

GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers

Cancer | Lung Cancer | Immunotherapy | CAR-T Cell

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Chemotherapy | Advanced Lung Cancer | Precision Cell Immunotherapy

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Oral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFR

China
Leiden University Medical Center
Jessa Hospital; The Netherlands Cancer Institute

Recruiting

Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy (Prediction)

Immunotherapy | Non Small Cell Lung Cancer Stage III

Netherlands, Belgium
Lei Li

Completed

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Chemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Non-small Cell Lung Cancer | Consolidation Immunotherapy | Radiotherapy or Sequential Chemoradiation

China
University Hospital, Grenoble
Jules Bordet Institute

Completed

Cancer Patients Treated With Immunotherapy in Intensive Care Unit (IMMUNO-REA)

Cancer | Critical Illness | Immunotherapy

Belgium, France
The Second Hospital of Shandong University

Recruiting

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Esophageal Cancer | Immunotherapy | Gastroesophageal Cancer | Adjuvant

China
Sun Yat-sen University
The First Affiliated Hospital of Guangzhou Medical University; Sixth Affiliated...

Recruiting

RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial (RAMEC)

Hepatectomy | Primary Liver Cancer | Immunotherapy | Radiofrequency Ablation

China
Hubei Cancer Hospital

Recruiting

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Radiotherapy | Immunotherapy | Advanced Non-Small Cell Squamous Lung Cancer

China
Fudan University

Recruiting

Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)

Non-small Cell Lung Cancer | Neoadjuvant Therapy | Immunotherapy | Stage II-IIIA

China
First Affiliated Hospital of Zhejiang University

Recruiting

Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma (TACT)

Neoadjuvant Therapy | Immunotherapy | Lung Squamous Cell Carcinoma

China
Fuzhou General Hospital

Recruiting

Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma

Immunotherapy Esophagus Cancer

China
University Hospital Center of Martinique
European Georges Pompidou Hospital

Completed

Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population (MituHPV)

Immunotherapy

France, Martinique
Ardigen
Małopolskie Centre of Entrepreneurship

Unknown

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Non Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer Vaccine

Poland
Guangdong Provincial People's Hospital

Completed

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Chemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, Residual

China
VA Office of Research and Development
Wayne State University; University of Michigan; Barbara Ann Karmanos Cancer Institute

Completed

Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy

Non-Small Cell Lung Cancer | Immunotherapy

United States
Henan Cancer Hospital

Unknown

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Small Cell Lung Cancer | Chemotherapy | Adoptive Cellular Immunotherapy | Maintenance | Extensive Disease

China
University Hospital, Strasbourg, France

Recruiting

Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.

NSCLC | IMMUNOTHERAPY | QUANTIFICATION OF CELL-FREE DNA

France
Bispebjerg Hospital

Unknown

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Immune Response | Immunotherapy | BCC - Basal Cell Carcinoma | Ablative Fractionated Laser

Denmark
Hospices Civils de Lyon

Unknown

ASIA Study : French Register of Inflammatory Eye Disease (ASIA)

Patients Treated for Cancer by Immunotherapy

France
Second Affiliated Hospital, School of Medicine,...

Recruiting

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

Ovarian Cancer | Neoadjuvant Chemotherapy | Anti-PD-1 | Neoadjuvant Immunotherapy

China
Michael Dill
University of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaborators

Not yet recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)

Immunotherapy

Germany
Tianjin Medical University Second Hospital

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Neoadjuvant Immunotherapy

China
Xinqiao Hospital of Chongqing

Not yet recruiting

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

NSCLC | Radiotherapy | Immunotherapy | Intensity Modulated Radiation Therapy
Shanghai Chest Hospital

Not yet recruiting

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) (RICE)

Chemotherapy | Immunotherapy | Concurrent Chemoradiotherapy | Esophageal Squamous Cell Carcinomas

Clinical Trials on Anti-cancer Cell Immunotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations